4.6 Article

Association of Plasma High-Density Lipoprotein Cholesterol Level With Risk of Fractures in Healthy Older Adults

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations

Chang Liu et al.

Summary: This cohort study examined the association between very high HDL-C levels (>80 mg/dL) and mortality in patients with coronary artery disease (CAD). The results demonstrated a U-shaped association, with higher risk of death in individuals with both low and very high HDL-C levels compared to those with midrange values. Specifically, very high HDL-C levels were associated with increased risk of all-cause death and cardiovascular death. These associations were independent of common genetic polymorphisms associated with high HDL-C levels.

JAMA CARDIOLOGY (2022)

Article Medicine, General & Internal

The Association of Lipids and Lipoproteins with Hip Fracture Risk: The Cardiovascular Health Study

Joshua Barzilay et al.

Summary: The study found that lipids and lipoproteins are associated with the risk of hip fractures in older adults, although the relationship is complex and multifaceted. Mechanistic studies are necessary to further understand these findings.

AMERICAN JOURNAL OF MEDICINE (2022)

Article Endocrinology & Metabolism

Detecting causal relationship between metabolic traits and osteoporosis using multivariable Mendelian randomization

Q. Zhang et al.

Summary: By adopting Mendelian randomization extension methods, potential causal risk factors for bone mineral density traits were identified, providing novel insights for the treatment and intervention of bone-related complex traits and diseases.

OSTEOPOROSIS INTERNATIONAL (2021)

Review Endocrinology & Metabolism

Blood lipid levels in patients with osteopenia and osteoporosis:a systematic review and meta-analysis

Hang Zhao et al.

Summary: In subjects not taking lipid-lowering drugs, there were no significant changes in total cholesterol, triglycerides, and low-density lipoprotein cholesterol in the osteopenia group. Postmenopausal women with osteopenia did not show significant differences in LDL-C. In the osteoporosis group without taking lipid-lowering drugs, triglycerides remained unchanged, while high-density lipoprotein cholesterol was elevated.

JOURNAL OF BONE AND MINERAL METABOLISM (2021)

Review Biochemistry & Molecular Biology

High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?

Andrea Bonnin Marquez et al.

BIOMEDICINES (2020)

Review Endocrinology & Metabolism

High-density lipoprotein (HDL) metabolism and bone mass

Nicholaos I. Papachristou et al.

JOURNAL OF ENDOCRINOLOGY (2017)

Article Geriatrics & Gerontology

Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study

John J. McNeil et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2017)

Article Medicine, General & Internal

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

A. Michael Lincoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Endocrinology & Metabolism

Triglyceride Levels and Fracture Risk in Midlife Women: Study of Women's Health Across the Nation (SWAN)

Po-Yin Chang et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Article Medicine, Research & Experimental

Apolipoprotein A-1 regulates osteoblast and lipoblast precursor cells in mice

Harry C. Blair et al.

LABORATORY INVESTIGATION (2016)